SCHEMBL8868264

SCHEMBL8868264

CCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(F)cc3)cc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
CNR1 P21554 1/20 0.44
CYP2C19 P33261 1/20 0.44
ADRA1A P35348 1/20 0.44
BLM P54132 1/20 0.44
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
P4HTM Q9NXG6 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869124 0.93 MAPT (0.48) MAPTLMNATP53KMT2AMEN1
SCHEMBL8868674 0.93 MAPT (0.48) MAPTLMNATP53KMT2AMEN1
SCHEMBL8869126 0.92 PPARA (0.51) MAPTLMNATP53KMT2AMEN1
SCHEMBL8868460 0.92 MAPT (0.52) MAPTLMNATP53KMT2AMEN1
SCHEMBL8868685 0.92 MAPT (0.52) MAPTLMNATP53KMT2AMEN1
SCHEMBL8868669 0.91 P4HTM (0.49) MAPTLMNATP53KMT2AMEN1
SCHEMBL8869027 0.91 P4HTM (0.55) MAPTLMNATP53KMT2AMEN1
SCHEMBL9137896 0.90 MAPT (0.55) MAPTLMNATP53KMT2AMEN1
SCHEMBL9139948 0.90 MAPT (0.55) MAPTLMNATP53KMT2AMEN1
SCHEMBL8868573 0.89 BCL2L1 (0.51) MAPTTP53KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed